Yvonne Bombard

Yvonne Bombard

Auto-generated profile, based on publicly available information

Yvonne Bombard

Genomics Health Services Research Program, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto, Toronto, Canada

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2018 in Implementation Science
Verified
Journal Article
Open access
PDF file
YBYvonne Bombard
Yvonne Bombard
GBG. Ross Baker
G. Ross Baker
EOElaina Orlando
Elaina Orlando
CFCarol Fancott
Carol Fancott
PBPooja Bhatia
Pooja Bhatia
MPMarie-Pascale Pomey
Marie-Pascale Pomey
To identify the strategies and contextual factors that enable optimal engagement of patients in the design, delivery, and evaluation of health services. We searched MEDLINE, EMBASE, CINAHL, Cochrane, Scopus, PsychINFO, Social Science Abstracts, EBSCO, and ISI Web of Science from 1990 to 2016 for empirical studies addressing the active participation of patients, caregivers, or families in the design, delivery and evaluation of health services to improve quality of care. Thematic analysis was used to identify (1) strategies and contextual factors that enable optimal engagement of patients, (2) outcomes of patient engagement, and (3) patients’ experiences of being engaged. Forty-eight studies were included. Strategies and contextual factors that enable patient engagement were thematically grouped and related to techniques to enhance design, recruitment, involvement and leadership action, and those aimed to creating a receptive context. Reported outcomes ranged from educational or tool development and informed policy or planning documents (discrete products) to enhanced care processes or service delivery and governance (care process or structural outcomes). The level of engagement appears to influence the outcomes of service redesign—discrete products largely derived from low-level engagement (consultative unidirectional feedback)—whereas care process or structural outcomes mainly derived from high-level engagement (co-design or partnership strategies). A minority of studies formally evaluated patients’ experiences of the engagement process (n = 12; 25%). While most experiences were positive—increased self-esteem, feeling empowered, or independent—some patients sought greater involvement and felt that their involvement was important but tokenistic, especially when their requests were denied or decisions had already been made. Patient engagement can inform patient and provider education and policies, as well as enhance service delivery and governance. Additional evidence is needed to understand patients’ experiences of the engagement process and whether these outcomes translate into improved quality of care. N/A (data extraction completed prior to registration on PROSPERO).

1 April 2019 in The American Journal of Human Genetics
Verified
Journal Article
Open access
YBYvonne Bombard
Yvonne Bombard
KBKyle B. Brothers
Kyle B. Brothers
SFSara Fitzgerald-Butt
Sara Fitzgerald-Butt
NGNanibaa’ A. Garrison
Nanibaa’ A. Garrison
LJLeila Jamal
Leila Jamal
HLHoward P. Levy
Howard P. Levy
The evidence base supporting genetic and genomic sequence-variant interpretations is continuously evolving. An inherent consequence is that a variant's clinical significance might be reinterpreted over time as new evidence emerges regarding its pathogenicity or lack thereof. This raises ethical, legal, and financial issues as to whether there is a responsibility to recontact research participants to provide updates on reinterpretations of variants after the initial analysis. There has been discussion concerning the extent of this obligation in the context of both research and clinical care. Although clinical recommendations have begun to emerge, guidance is lacking on the responsibilities of researchers to inform participants of reinterpreted results. To respond, an American Society of Human Genetics (ASHG) workgroup developed this position statement, which was approved by the ASHG Board in November 2018. The workgroup included representatives from the National Society of Genetic Counselors, the Canadian College of Medical Genetics, and the Canadian Association of Genetic Counsellors. The final statement includes twelve position statements that were endorsed or supported by the following organizations: Genetic Alliance, European Society of Human Genetics, Canadian Association of Genetic Counsellors, American Association of Anthropological Genetics, Executive Committee of the American Association of Physical Anthropologists, Canadian College of Medical Genetics, Human Genetics Society of Australasia, and National Society of Genetic Counselors.

8 August 2021 in Human Genetics
Verified
Journal Article
Closed access
PDF file
SSSalma Shickh
Salma Shickh
CMChloe Mighton
Chloe Mighton
EUElizabeth Uleryk
Elizabeth Uleryk
PPPetros Pechlivanoglou
Petros Pechlivanoglou
YBYvonne Bombard
Yvonne Bombard

14 September 2020 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
CMChloe Mighton
Chloe Mighton
SSSalma Shickh
Salma Shickh
EUElizabeth Uleryk
Elizabeth Uleryk
PPPetros Pechlivanoglou
Petros Pechlivanoglou
YBYvonne Bombard
Yvonne Bombard

7 July 2022 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
YBYvonne Bombard
Yvonne Bombard
GGGeoffrey S. Ginsburg
Geoffrey S. Ginsburg
ASAmy C. Sturm
Amy C. Sturm
AZAlicia Y. Zhou
Alicia Y. Zhou
ALAmy A. Lemke
Amy A. Lemke

1 July 2011 in Social Science & Medicine
Verified
Journal Article
Closed access
YBYvonne Bombard
Yvonne Bombard
JAJulia Abelson
Julia Abelson
DSDorina Simeonov
Dorina Simeonov
FGFrancois-Pierre Gauvin
Francois-Pierre Gauvin